<DOC>
	<DOCNO>NCT02744690</DOCNO>
	<brief_summary>This study randomize , double-masked trial examine response trabeculectomy surgery . In study , patient randomize receive MMC via subconjunctival injection topical sponge application .</brief_summary>
	<brief_title>Mitomycin C Trabeculectomy Trial Glaucoma Ethiopia</brief_title>
	<detailed_description>This study randomize , double-masked ( study participant outcome assessor ) trial . During enrollment period , patient Menelik Hospital plan trabeculectomy surgery meet study enrollment criterion randomize receive mitomycin C apply topically injection surgery.At Menelik Hospital mitomycin-C ( MMC ) routinely apply eye prior trabeculectomy physician via sponge injection route . The primary outcome patient 's response trabeculectomy procedure , measure cumulative complication 3-month follow-up period post-operation . Secondary outcome change intraocular pressure 3 month follow-up period . The investigator perform subgroup analysis stratify population accord skin pigmentation determine whether pigmentation predictor treatment success .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Age &gt; =40 Planning trabeculectomy Life threaten debilitate disease Inability complete necessary exam and/or ocular disease would preclude assessment intraocular pressure , visual field , optic disc Pseudophakic lens Contralateral eye already enrol study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Eye Disease</keyword>
	<keyword>Intraocular Pressure</keyword>
	<keyword>Visual Acuity</keyword>
	<keyword>Trabeculectomy</keyword>
</DOC>